New grad roles at Celea Therapeutics
Celea Therapeutics is a clinical-stage biopharmaceutical company developing next-generation treatments for serious respiratory diseases. Its lead program, deupirfenidone, is in Phase 3 development for idiopathic pulmonary fibrosis and other fibrotic lung diseases.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Open roles
- 4
Get new Celea Therapeutics new grad roles by email
Free account. Get new Celea Therapeutics new grad roles by email or push the minute they post.
